Senior insider sale
EVP, Chief Human Resources Ofc at IONIS PHARMACEUTICALS INC — senior position signals high conviction
$7.82M
95.54K shares
What this filing means
DEVERS SHANNON L. plans to sell 95.54K shares of IONIS PHARMACEUTICALS INC valued at approximately $7.82M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/3/2026ACC: 0001972481-26-000077
Officer· EVP, Chief Human Resources Ofc
Since Mar 2026
95.54K
Shares to sell
$7.82M
Approx. market value
36.04K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months4
Restricted Stock Units
Equity Compensation
1/13/2024
15.94KOption Exercise
Cash
1/2/2024
10.46KOption Exercise
Cash
1/3/2023
4.14KOption Exercise
Cash
1/3/2022
5.50KTotal acquired36.04K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/13/2024 | Restricted Stock Units Equity Compensation | 15.94K | — |
1/2/2024 | Option Exercise Cash | 10.46K | — |
1/3/2023 | Option Exercise Cash | 4.14K | — |
1/3/2022 | Option Exercise Cash | 5.50K | — |
| Total | 36.04K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
3.98K
Market value
$323.5K
1/22/2026
—Completed
Units to sell
8.35K
Market value
$636.6K
1/16/2026
—Completed
Units to sell
44.20K
Market value
$3.76M
1/7/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
39.01K
Market value
$3.10M
3/3/2026
Total
Units
95.54K
Value
$7.82M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/22/2026 | 3.98K | $323.5K | — | Completed |
1/16/2026 | 8.35K | $636.6K | — | Completed |
1/7/2026 | 44.20K | $3.76M | — | Completed |
| Planned — Approximate Date | ||||
3/3/2026 | 39.01K | $3.10M | Nasdaq | Planned |
| Total | 95.54K | $7.82M | ||